Poverty and social disadvantage in women and men and fertility outcomes
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Oct-2025 15:11 ET (13-Oct-2025 19:11 GMT/UTC)
The American Academy of Pediatrics (AAP) is hosting its 2025 National Conference & Exhibition will take place in Denver for the first time, providing an opportunity for pediatricians and other to learn the latest in medical research and collaborate on how to improve children’s health.
The conference, held from Friday, Sept. 26 through Tuesday, Sept. 30, at the Colorado Convention Center, includes educational sessions, an exhibit hall with hundreds of booths, and motivating plenary sessions. More than 10,000 people have registered to attend, representing 71 nations.
The gut microbiota is widely recognized as a central regulator of human health and disease. Medicine-food homologous resources, leveraging their inherent safety and multi-target characteristics, serve as pivotal modulators for intervening in metabolic, inflammatory, and immune-related disorders via microbiota regulation. However, the inherent complexity, substantial interindividual variability, and dynamic nature of the gut microbiome remain major hurdles to achieving precise interventions. This perspective delineates a novel paradigm for precision medicine-food intervention, built upon three interconnected and cutting-edge directions: (1) targeting key microbial metabolites, (2) advancing targeted delivery technologies for beneficial microbes, and (3) implementing artificial intelligence (AI)-assisted personalized microbiome functional profiling. This triad synergistically addresses the challenge of individual variability and paves the way for highly effective and precise interventions.
The principle of "food and medicine homology" (FMH), deeply embedded in traditional Chinese medicine, posits that certain natural substances can function as both food and medicine. A recent opinion piece posits that substances with FMH properties, recognized for their nutritional benefits and minimal toxicity, may present innovative opportunities in supplementary cancer treatment and prevention. The authors underscore the solid theoretical underpinnings and international acknowledgement of this approach, emphasizing how cutting-edge technologies can substantiate these age-old practices and facilitate their incorporation into modern, comprehensive cancer management programs.